Co-Diagnostics, Inc. CODX stock is trading higher on Wednesday as the company announced a private placement aimed at raising ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Stocktwits on MSN
CODX stock explodes over 630% in six sessions – retail traders bet the rally isn’t over yet
The company is working alongside its Indian JV, CoSara Diagnostics, to support faster international deployment if the outbreak spreads globally. ・The program includes both Bundibugyo-specific and ...
Investors might want to bet on Co-Diagnostics, Inc. (CODX), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
Product Revenue -- $0.4 million, decreased from $0.8 million, reflecting limited commercial activity and ongoing investment ...
The molecular diagnostics firm revealed it has signed a Memorandum of Understanding with a Saudi Arabian partner to potentially create a joint venture aimed at developing and distributing its Co-Dx™ ...
New York City, Dec. 19, 2019 (GLOBE NEWSWIRE) -- The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with a patented platform for the development of molecular diagnostic tests that has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results